These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Latest overview of type 1 diabetes mellitus]. Miura J; Uchigata Y Nihon Rinsho; 2008 Jul; 66(7):1397-404. PubMed ID: 18616134 [TBL] [Abstract][Full Text] [Related]
3. [Regenerative cell therapy of the type I diabetes mellitus and its complications]. Zakir'ianov AR; Onishchenko NA; Klimenko ED; Pozdniakov OM Vestn Ross Akad Med Nauk; 2008; (3):42-51. PubMed ID: 18421908 [TBL] [Abstract][Full Text] [Related]
4. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of diabetic complications. Forbes JM; Cooper ME Physiol Rev; 2013 Jan; 93(1):137-88. PubMed ID: 23303908 [TBL] [Abstract][Full Text] [Related]
6. Islet neogenesis: a potential therapeutic tool in type 1 diabetes. Lipsett M; Aikin R; Castellarin M; Hanley S; Jamal AM; Laganiere S; Rosenberg L Int J Biochem Cell Biol; 2006; 38(4):498-503. PubMed ID: 16216541 [TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetes: pathogenesis and prevention. Gillespie KM CMAJ; 2006 Jul; 175(2):165-70. PubMed ID: 16847277 [TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes mellitus: etiology, presentation, and management. Haller MJ; Atkinson MA; Schatz D Pediatr Clin North Am; 2005 Dec; 52(6):1553-78. PubMed ID: 16301083 [TBL] [Abstract][Full Text] [Related]
9. The role of new technologies in treating children and adolescents with type 1 diabetes mellitus. Shalitin S; Phillip M Pediatr Diabetes; 2007 Oct; 8 Suppl 6():72-9. PubMed ID: 17727388 [TBL] [Abstract][Full Text] [Related]
10. Type 1 diabetes intervention trials 2007: where are we and where are we going? Haller MJ; Gottlieb PA; Schatz DA Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):283-7. PubMed ID: 17940453 [TBL] [Abstract][Full Text] [Related]
11. Personalized epigenetic management of diabetes. Fodor A; Cozma A; Karnieli E Per Med; 2017 Nov; 14(6):531-549. PubMed ID: 29749858 [TBL] [Abstract][Full Text] [Related]
12. Tight control of type 1 diabetes: recommendations for patients. Havas S; Donner T Am Fam Physician; 2006 Sep; 74(6):971-8. PubMed ID: 17002031 [TBL] [Abstract][Full Text] [Related]
13. Genetics for targeting disease prevention: diabetes. Newell AM Prim Care; 2004 Sep; 31(3):743-66, xii. PubMed ID: 15331257 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of diabetes mellitus type 1]. Scherbaum WA; Hauner H Dtsch Med Wochenschr; 2005 Jan; 130(4):141-2. PubMed ID: 15662579 [TBL] [Abstract][Full Text] [Related]
15. Immune intervention for type 1 diabetes mellitus. Skyler JS Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814 [TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Atkinson MA; Eisenbarth GS Lancet; 2001 Jul; 358(9277):221-9. PubMed ID: 11476858 [TBL] [Abstract][Full Text] [Related]
17. [Mapping of protective factors in type 1 diabetes has begun. Some patients appear to be protected against late complications--Several studies are underway]. Lyssenko V; Nilsson PM Lakartidningen; 2012 Apr 4-10; 109(14-15):744-5. PubMed ID: 22611878 [No Abstract] [Full Text] [Related]
18. Diabetes cure--is the glass half full? Bromberg JS; LeRoith D N Engl J Med; 2006 Sep; 355(13):1372-4. PubMed ID: 17005956 [No Abstract] [Full Text] [Related]
20. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention. Giannoukakis N; Pietropaolo M; Trucco M Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]